gx-03
Small moleculeexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 21, 2021 (NCT04951349)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04951349 | Phase 2 | Jan 21, 2021 | Hospital Modular - Covid-19, Hospital Punta Pacifica, Hospital Santo Tomas, Turn Therapeutics, University of Alabama, Birmingham |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital Modular - Covid-19 | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Hospital Punta Pacifica | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Hospital Santo Tomas | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Turn Therapeutics | For profit | 1 | 1 | 1 | 2021 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1